1
|
Jiang B, Lyu FN, Zheng XY, Cao Y, Mi YQ. [Potential clinical value of new type of HBV serological markers ranking in the review column]. Zhonghua Gan Zang Bing Za Zhi 2020; 28:711-714. [PMID: 32911913 DOI: 10.3760/cma.j.cn501113-20190724-00268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Liver fibrosis, liver cirrhosis and hepatocellular carcinoma caused by chronic hepatitis B are still the main diseases that seriously affect the health of Chinese population. Notably, even if serum HBV-DNA cannot be detected after treatment, many patients will still develop liver disease. Therefore, in addition to the quantitative analysis of HBV-DNA and HBsAg, other new serological markers should be sought to facilitate the selection of CHB antiviral drugs and methods, monitoring efficacy and follow-up, efficacy prediction, and the risks of viral rebound after drug withdrawal. This article focuses on three new serological markers, namely HBcrAg, HBV-RNA and anti-HBc, with a view to applying them in clinical practice.
Collapse
Affiliation(s)
- B Jiang
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| | - F N Lyu
- Graduate School, Tianjin Medical University, Tianjin 300070, China
| | - X Y Zheng
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| | - Y Cao
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| | - Y Q Mi
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| |
Collapse
|
2
|
Xu L, Zhong Y, Su ST, Liu YG, Lyu FN, Zhou XL, Ren JQ, Li P, Shi RF, Jiang Y, Fan JG, Mi YQ. [Study of reactive oxygen species and adiponectin for chronic HBV infection combined with nonalcoholic fatty liver diseases]. Zhonghua Gan Zang Bing Za Zhi 2020; 28:247-253. [PMID: 32306658 DOI: 10.3760/cma.j.cn501113-20191231-00486] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the application value of reactive oxygen species (ROS) and adiponectin (ADPN) in the judgment of liver inflammation in chronic hepatitis B virus infection combined with nonalcoholic fatty liver disease (NAFLD). Methods: A total of 159 cases with NAFLD (21 cases), chronic hepatitis B virus infection (57 cases), and chronic hepatitis B virus infection combined with NAFLD (81 cases) were collected between June 2016 to December 2018, and the visited patients diagnosis were confirmed by histopathological examination of the liver. ROS and ADPN level retained in serum was determined by enzyme-linked immunosorbent assay. Histopathological examination of liver tissue was used as the gold standard to discuss the diagnostic value of the serum in patients with chronic hepatitis B virus infection combined with NAFLD for the occurrence of nonalcoholic steatohepatitis. One-way analysis of variance was used for the comparison among multiple groups, and LSD-t test was used for pairwise comparison between groups. Measurement data for non-normal distributions were expressed as M (P25, P75). Comparisons between groups were performed using the Mann-Whitney U or Kruskal-Wallis H test. Chi-square test was used to compare the count data between groups. Correlation analysis was performed using Spearman correlation analysis. Histopathological grouping of liver tissue was used as the gold standard, and the area under the receiver operating characteristic curve was used to evaluate the diagnostic efficacy of the regression formula. Results: (1) In patients with chronic hepatitis B virus infection combined with NAFLD, the levels of ROS in the non-hepatic steatosis group and the mild hepatic steatosis group were significantly lower than those in the moderate and severe hepatic steatosis group, while the ADPN level in the non-hepatic steatosis group was significantly higher than liver steatosis group, P < 0.05. (2) The results of correlation analysis showed that ROS was significantly correlated with NAS score, change in the degree of fatty liver and lobular inflammation (all P < 0.05).There was a significant negative correlation between ADPN and the change in the degree of fatty liver (P < 0.05). (3) Logistic regression analysis results showed that the diagnostic formula for chronic hepatitis B virus infection combined with nonalcoholic steatohepatitis was 0.02 × controlled attenuation index + 0.584 × white blood cells/10(9) + 0.587 × ROS-10.982. The area under receiver operating characteristic curve of the subject was = 0.896. The sensitivity, specificity, positive and negative predictive value were 97.1%, 71.2%, 64.2%, and 97.9%. Conclusion: ADPN and ROS have certain reference value in differentiating the change in the degree of fatty liver and inflammation in chronic hepatitis B virus infection combined with NAFLD and the diagnostic formula has higher application value in the diagnosis and exclusion of chronic hepatitis B virus infection combined with nonalcoholic steatohepatitis.
Collapse
Affiliation(s)
- L Xu
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| | - Y Zhong
- Yanqing County Hospital of Beijing (Yanqing hospital, the Third Hospital of Peking University), Beijing 102100, China
| | - S T Su
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| | - Y G Liu
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| | - F N Lyu
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| | - X L Zhou
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| | - J Q Ren
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| | - P Li
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| | - R F Shi
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| | - Y Jiang
- Department of Gastroenterology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China
| | - J G Fan
- Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University STCol of Medicine, Shanghai 200092, China
| | - Y Q Mi
- Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin 300192, China
| |
Collapse
|
3
|
Jiang B, Liu C, Su R, Meng C, Cao Y, Zheng XY, Ren WJ, Lyu FN, Lu W. [Value of serum HBV RNA in HBeAg-negative patients with chronic hepatitis B]. Zhonghua Gan Zang Bing Za Zhi 2019; 27:668-672. [PMID: 31594089 DOI: 10.3760/cma.j.issn.1007-3418.2019.09.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze serum HBV-RNA levels in patients with chronic hepatitis B whose serum HBV-DNA has dropped to undetected levels after treatment with entecavir, and to explore the correlation between HBV-RNA level and liver biochemical parameters, which lay the research foundation for the clinical significance of new serological marker HBV-RNA. Methods: HBeAg negatively detected 107 cases with chronic hepatitis B whose serum HBV-DNA test results were lower than detection level for six consecutive months after receiving standard nucleoside therapy for more than 12 months were included. HBV-RNA level was detected by Perkin-Elmer reagent. HBV-DNA level was detected by Roche Cobas. Hitachi automatic biochemical analyzer was used to detect ALT and AST. Architect chemiluminescence analyzer was used to detect HBsAg, HBeAg, anti-HBe and anti-HBc. RStudio software was performed to analyze the correlation between HBV-RNA level and liver biochemical parameters. Logistic regression was used to analyze the independent factors influencing HBV-RNA level. Results: The positive detection rate of serum HBV-RNA in patients with chronic hepatitis B whose serum HBV-DNA had dropped to undetected levels after ETV treatment was 22.43%. HBsAg, ALT and AST levels in HBV-RNA positive group were slightly higher than HBV-RNA negative group, while anti-HBc levels were slightly higher in HBV-RNA negative group. There was no difference in the level of anti-HBe between the HBV-RNA negative and the positive group. Logistic regression analysis showed that anti-HBc was an independent factor influencing the level of HBV-RNA detection (P = 0.021). Conclusion: HBV-RNA can be detected in some patients with chronic hepatitis B whose serum HBV-DNA level has dropped to undetected levels after ETV treatment. Serum HBV-RNA only comes from the direct transcription of cccDNA, so it is better than HBV-DNA and HBsAg to reflect cccDNA level or activity. Anti-HBc, as an independent factor influencing the level of HBV-RNA, may be used in combination as a new marker to predict the efficacy of antiviral therapy.
Collapse
Affiliation(s)
- B Jiang
- Tianjin Second People's Hospital, Tianjin institute of Hepatology, Tianjin 300192, China
| | | | | | | | | | | | | | | | | |
Collapse
|